Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/C83DBFAD.svg?ark=w1%2F20260515%2FC83DBFAD)](https://nobleid.org/work/w1/20260515/C83DBFAD)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors